Atara Biotherapeutics
ATRA
ATRA
139 hedge funds and large institutions have $1.5B invested in Atara Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 140 → 139 (-1)
7% less capital invested
Capital invested by funds: $1.61B → $1.5B (-$106M)
Holders
139
Holding in Top 10
3
Calls
$1.01M
Puts
$261K
Top Buyers
| 1 | +$36.2M | |
| 2 | +$18M | |
| 3 | +$17.8M | |
| 4 |
Citigroup
New York
|
+$11.7M |
| 5 |
N
Natixis
Paris,
France
|
+$10M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$12.6M | |
| 3 | -$9.44M | |
| 4 |
LPC
Lion Point Capital
New York
|
-$6.27M |
| 5 |
Two Sigma Advisers
New York
|
-$5.16M |